These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 101464)

  • 1. Pseudomonas ribosomal vaccines: preparation, properties, and immunogenicity.
    Lieberman MM
    Infect Immun; 1978 Jul; 21(1):76-86. PubMed ID: 101464
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Passive immunization against Pseudomonas with a ribosomal vaccine-induced immune serum and immunoglobulin fractions.
    Lieberman MM; McKissock DC; Wright GL
    Infect Immun; 1979 Feb; 23(2):509-21. PubMed ID: 106013
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serotype-nonspecific protection induced by ribonucleic acid isolated from the ribosomal vaccine of Pseudomonas aeruginosa.
    Gonggrijp R; Mullers WJ; van Boven CP
    Infect Immun; 1981 Jul; 33(1):178-85. PubMed ID: 6167518
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ribonuclease-sensitive ribosomal vaccines.
    Gonggrijp R; Antonissen AC; van den Bosch JF; van Boven CP
    Antonie Van Leeuwenhoek; 1984; 50(5-6):763-74. PubMed ID: 6084981
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ribonuclease-sensitive ribosomal vaccine of Pseudomonas aeruginosa.
    Gonggrijp R; Mullers WJ; Lemmens PJ; van Boven CP
    Infect Immun; 1980 Jan; 27(1):204-10. PubMed ID: 6153637
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunogenic dialyzable factor derived from a ribosomal fraction of Salmonella typhimurium. I. Preparation of the protective dialyzable factor from the ribosomal fraction by the freeze-thaw procedure.
    Kita E; Matsuura H; Masuda S; Tomihata S; Kashiba S
    Microbiol Immunol; 1983; 27(1):7-24. PubMed ID: 6346023
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polyvalent antisera to Pseudomonas ribosomal vaccines: protection of mice against clinically isolated strains.
    Lieberman MM; Wright GL; Wolcott KM; McKissock-Desoto DC
    Infect Immun; 1980 Aug; 29(2):489-93. PubMed ID: 6783532
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pseudomonas aeruginosa antigens as potential vaccines.
    Stanislavsky ES; Lam JS
    FEMS Microbiol Rev; 1997 Nov; 21(3):243-77. PubMed ID: 9451816
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Active and passive immunity against Pseudomonas aeruginosa with a ribosomal vaccine and antiserum in C3H/HeJ mice.
    Lieberman MM; Ayala E
    J Immunol; 1983 Jul; 131(1):1-3. PubMed ID: 6408166
    [No Abstract]   [Full Text] [Related]  

  • 10. Effect of trypsin and ribonuclease on the immunogenic activity of ribosomes and ribonucleic acid isolated from Mycobacterium tuberculosis.
    Youmans AS; Youmans GP
    J Bacteriol; 1966 Jun; 91(6):2146-54. PubMed ID: 4957610
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ribosomal vaccines. I. Immunogenicity of ribosomal fractions isolated from Salmonella typhimurium and Yersinia pestis.
    Johnson W
    Infect Immun; 1972 Jun; 5(6):947-52. PubMed ID: 4564407
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pseudomonas aeruginosa ribosomal vaccine. A comparison of the immunogenicity of vaccines from two different serotypes.
    Lieberman MM
    Antibiot Chemother (1971); 1989; 42():193-202. PubMed ID: 2512837
    [No Abstract]   [Full Text] [Related]  

  • 13. Isolation and partial characterization of an immunogenic moiety obtained from Salmonella typhimurium.
    Venneman MR; Bigley NJ
    J Bacteriol; 1969 Oct; 100(1):140-8. PubMed ID: 4898982
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of ribosomal preparations from Pseudomonas aeruginosa to protect against intravenous Pseudomonas challenge in mice.
    Smith RL; Wysocki JA; Bruun JN; De Courcy SJ; Blakemore WS; Mudd S
    J Reticuloendothel Soc; 1974 Jan; 15(1):22-30. PubMed ID: 4204145
    [No Abstract]   [Full Text] [Related]  

  • 15. Specificity of the protective response induced by the slime layer of Pseudomonas aeruginosa.
    Mates A; Zand P
    J Hyg (Lond); 1974 Aug; 73(1):75-84. PubMed ID: 4213979
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Cell-free Pseudomonas vaccine: its immunochemical characteristics and immunogenicity].
    Bandman OA; Edvabnaia LS; Bulk VF; Zhvanetskaia MI; Mashilova GM
    Zh Mikrobiol Epidemiol Immunobiol; 1987 Nov; (11):44-7. PubMed ID: 3124416
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Active and passive immunization with Pseudomonas aeruginosa ribosomal vaccines and antisera in the burned rat model.
    Lieberman MM; Walker HL; Ayala E; Chapa I
    J Surg Res; 1986 Feb; 40(2):138-44. PubMed ID: 3080639
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A new polyvalent Pseudomonas vaccine.
    Miler JM; Spilsbury JF; Jones RJ; Roe EA; Lowbury EJ
    J Med Microbiol; 1977 Feb; 10(1):19-27. PubMed ID: 402473
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibacterial immunity induced by ribosomal vaccines.
    Winston SH; Berry LJ
    J Reticuloendothel Soc; 1970 Jul; 8(1):13-24. PubMed ID: 4988339
    [No Abstract]   [Full Text] [Related]  

  • 20. Protective mechanism of the immune response to a ribosomal vaccine from Pseudomonas aeruginosa. I. In vivo protection studies in compromised animal models.
    Lieberman MM; Frank WJ
    J Surg Res; 1988 Mar; 44(3):242-50. PubMed ID: 3125388
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.